Medizone Home

Save the date – expopharm 27. – 29. September 2023

Save the date – we will have a booth again this year at expopharm Düsseldorf, 27th to 29th September 2023, and hope that we can welcome you again in Hall 03 / Booth 3D75.

For more information visit expopharm

Meet us at Pharmagora Plus – 11-12 march 2023 – Paris

We are looking forward to meet you at  Pharmagora Plus 11.-12.3.2023

Dial +49 89 1211 2636 and we’ll be happy to arrange an appointment.

Thanks for visiting us at ARAB HEALTH 2023

Thank you for visiting us at Arab Health this year!

It was a great pleasure to have the opportunity again to speak in person with many of our business partners.

We will be back in 2024!




Medizone unterstützt die McDonald’s Kinderhilfe Stiftung

Wir unterstützen die McDonald’s Kinderhilfe Stiftung.
Im Ronald McDonald Haus in München-Großhadern können Familien ganz nah bei ihren schwer kranken Kindern sein und ihnen Liebe, Kraft und Zuversicht schenken. Medizone ermöglicht durch die Patenschaft für das Apartment 11, dass Familien schwer kranker Kinder hier ein Zuhause auf Zeit finden.



Meet us at Expopharm 2022 – München 14th to 17th September

We will have a booth again this year at expopharm München, 14th to 17th September, and hope that we can welcome you again in Hall B2 / Booth C28.

For more information visit expopharm exhibitor director

Meet us at CTS Europe 2022 – Madrid 22.-23.3.

We are looking forward to meet you at CTS Europe 2022 from 22.-23.3.2022
– please contact
Mrs. Cinzi Adorni – Account Manager CTS –
Mr. Gerhard Hoerl – Manging Director –

or dial +49 89 1211 2636 and we’ll be happy to arrange an appointment.

Meet us at CPhI 2021 – Milan 9th to 11th November

We are looking forward to meet you at CPhI Milan from the 9th to 11th November 2021
– please contact
Mr. Robin Mangler – Head of International Pharma Sales –
Mr. Klajdi Drini – Sales Support Manager –
or dial +49 89 1211 2636 and we’ll be happy to arrange an appointment.

For more information visit CPhI exhibitor directory.

Absage expopharm 2021

Absage expopharm 2021  – 22. – 25. September 2021 – Europas größte Fachmesse in Düsseldorf rund um den Apothekenmarkt wird nicht stattfinden.


Russia registers new Covid-19 drug to keep complications caused by virus ‘under control’

Russian developers have registered a new drug that may help alleviate the harshest complications caused by Covid-19, including lung failure. It’s hoped the treatment can buy time before a vaccine is found.

Levilimab is the second medication to receive state approval through a fast-track mechanism, implemented to give doctors more options to tackle the virus, which has already infected more than 459,000 and killed 5,725 in Russia, according to official statistics.

By reducing the Covid-19 mortality rate, Levilimab will allow Russia to “buy time” before the vaccine against the coronavirus is made, and “the vaccine is surely coming soon,” .

The drug is aimed at curbing the so-called ‘cytokine storm,’ a common complication from Covid-19 when the sick person’s immune system overreacts to the virus and the excessive inflammation leads to fatal outcome.

Levilimab’s highlight is that it can be administered not only to patients already in a serious condition, but used as a prophylactic to “prevent the ‘cytokine storm’ from occurring and allowing the patient to avoid intensive care and lung ventilation,” he pointed out.

The drug, which will go into the market under the brand ILSIRA, is administered hypodermically unlike its foreign counterparts, which get into the system through the intravenous route.

Levilimab has proven itself as effective as its foreign counterparts and increased the speed of recovery for patients, Ekaterina Trifonova, who heads the infectious ward at the Central Clinical Hospital in Moscow, where the drug underwent clinical testing, told RT. During the first two weeks of trials, out of 45 Covid-19 patients who got the drug, ten were discharged, including a 92-year-old-man, while the rest remained in satisfactory condition, she added.

Source: Biocad press release

Pharmagora Plus – Paris – cancelled June 27-28, 2020 – new dates March 13-14, 2021

Due to the current situation of the coronavirus epidemy, the French Minister of Health, Mr Olivier Véran, has forbidden the organization of any event with more than 5000 delegates in a closed environment. As a result, PharmogaraPlus 2020 will not take place on the 27th and 28th of June 2020 at Paris Porte de Versailles, Hall 3.

PharmagoraPlus is now postponed to the 13th and 14th of March 2021.

We look forward to meeting you soon.